Clinical development of core pipeline products continues
2024年Hyper Core 速聚芯™ 系列高性能材料白皮书
Core Laboratories Inc 2025年季度报告
1Q24 core earnings beat estimates; Shifted to profitable growth strategy
Core business recovery on track with more to expect on new initiatives
Core earnings a nice beat; Cloud revenue growth has the potential to accelerate further
Solid core businesses; upbeat on long-term development of e-commerce and AI
美国 Core Scientific Inc 美国上市招股说明书(2025年3月13日版本)
1H23 core profit +10% YoY; positive on the structural growth and mgmt. execution
美团(3690 HK): 核心本地商业利润增长超预期,优选亏损继续环比收窄—维持优于大市; 上调目标价28%(Meituan: Core Local Business Profit Growth Exceeds Expectations, Preferre